Frontiers | Combination of Angiotensin (1-7) Agonists and Convalescent Plasma as a New Strategy to Overcome Angiotensin Converting Enzyme 2 (ACE2) Inhibition for the Treatment of COVID-19
Cancers | Free Full-Text | Neprilysin Inhibition in the Prevention of Anthracycline-Induced Cardiotoxicity